IFN-γ-stimulated MSCs shave increased immunosuppressive capabilities [21] and are more efficient in the prevention of colitis [22], graft-versus-host disease (GVHD) [23, 24], and autoimmune encephalomyelitis [25] and in wound healing [26] compared to untreated cells. The gene discussed is IFNG; the disease is graft versus host disease.